Ablatherm® HIFU benefits
Being the least invasive prostate cancer treatment option available today, Ablatherm® HIFU has an excellent risk/benefit ratio proven by several clinical publications displaying coherent results.
Ablatherm® HIFU : a state-of-the-art robotic assistant
Ablatherm® HIFU has now been used for more than 15 years as and the results that have been monitored from the very beginning demonstrate that it is an efficient tool for urologists to treat localized prostate cancer (T1 - T2) and preserve patient quality of life.
Benefits : the least invasive option available today
Many patients cannot tolerate the side effects associated with radiation. Additionally, not all prostate cancer patients can or want to undergo surgery (radical prostatectomy). For these patients Ablatherm® Robotic HIFU® offers an excellent alternative with many advantages:
- Adjustable treatment strategy
- Flexible patient management
- Minimally-invasive - Radiation free

1. HIFU technology developed by Inserm for :
- Precise and irreversible coagulation necrosis
- Preservation of surrounding tissue
3 treatment options with distinct power algorithms
- First-line treatment
- Repeat treatment
- Recurrence after EBRT
- Complete, partial or nerve-sparing treatment strategy
3. Flexible patient management
Early feed-back with Nadir PSA- Repeatable treatment (with no Gleason score increase)
- Does not foreclude other treatment options
4. Minimally-invasive - Radiation free
- Short hospital stay (1-3 days)
- Spinal anaesthesia (or general)
- Short recovery time
For further clinical information and all latest publications on Ablatherm® HIFU, click here.
Hifu Planet a patient web site
HIFU PLANET website was set up to provide patients with useful information relating to prostate cancer treatments and particularly on Ablatherm® HIFU treatment. The web site is now available in several languages.
www.hifu-planet.co.uk
www.hifu-planet.fr
www.hifu-planet.de
www.hifu-planet.it
...

